Cannabis
Bluegrass Farmaceuticals signs entertainment icon Nelly as strategic partner: Changing the way the world consumes botanical therapeutics
Bluegrass Farmaceuticals, a botanical therapeutics company, announced today that it has entered into a strategic partnership with entertainer, icon and businessman Nelly. The partnership is Bluegrass Farmaceuticals’ first association with a high-profile public figure.
Nelly said, “A lot of people recognize me as an entertainer, but don’t know about all the other projects I passionately work on. Doing something that has a positive impact on people’s lives is extremely important to me. That’s why I chose to partner with Bluegrass [Farmaceuticals]. They’re creating products that will have an immediate effect on the lives of thousands… probably millions. I knew I had to be involved.”
Bluegrass Farmaceuticals produces natural health and wellness products including select botanical preparations and in-home technology for extraction and consumption of botanical therapeutics. The first devices designed to facilitate in-home extraction and consumption of Cannabis nanotherapeutics include High Note, FizzyFreak, NXtract & BudderFly. Several other devices, botanical products and patches are under development and the company has filed several patents.
Bluegrass Farmaceuticals’ Chief Executive Officer, Dan Zhu (Danielle) Tumey, highlights the great match between Nelly’s profile and the unique mission of the company: “Unlike most cannabis-derived product companies, Bluegrass Farmaceuticals will only create ‘pharmaceutical grade’ products, and Nelly’s involvement with innovative ways of fighting health and social problems fits with our mission.”
Bluegrass Farmaceuticals utilizes a proprietary extraction process that improves the cannabinoid and terpene extraction profiles and provides complete control over the quality of the product.
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
Cannabis
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
SCHWAZZE2 weeks ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis5 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis4 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan4 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey